FDA.reportPublic FDA data

TRIPLE ACTION ARTHRITIS

Product NDC
71049-101
Requested package NDC
71049-101-12
11-digit product format
710490101
Labeler code
71049
Product ID
71049-101_f217b960-b5be-3e9f-e053-2a95a90ade90
Type
HUMAN OTC DRUG
Nonproprietary name
METHYL SALICYLATE, MENTHOL, CAPSAICIN
Dosage form
CREAM
Route
TOPICAL
Labeler
WONG CHARKKEN BILL
Application
part348
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2016-10-22
Marketing end
0000-00-00
Substance
CAPSAICIN; MENTHOL; METHYL SALICYLATE
Active strength
0 g/100g; g/100g; g/100g
NDC exclude flag
No
Listing certified through
2024-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage71049-10171049-101-12DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71049-101-122024-01-30C16284748780-1ba0f9c33-3687-a910-e053-dadaa90a0b85ABC - TRIPLE ACTION ARTHRITIS CREAM (71049-101)
71049-101-122021-12-15C16284748780-1ba0f9c33-3687-a910-e053-dadaa90a0b85ABC - TRIPLE ACTION ARTHRITIS CREAM (71049-101)
71049-101-122021-01-29C16284748780-1ba0f9c33-3687-a910-e053-dadaa90a0b85ABC - TRIPLE ACTION ARTHRITIS CREAM (71049-101)

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71049-101-127104901011260 g in 1 JAR (71049-101-12) 60 g2016-10-220000-00-00NoNoCurrent